Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liye He

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2025
Protein Profiles Predict Treatment Responses to the PI3K Inhibitor Umbralisib in Patients with Chronic Lymphocytic LeukemiaYanping Yin, Haifeng Xu, Liye He, et al.
Journal of Biomaterials Applications|November 4, 2024
Inhibitory effect of RGD peptide hydrogel on inflammation and angiogenesis in vitroBinlin Chen, Licheng Liang, Dadong Jia, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|July 5, 2016
Comprehensive analysis of microRNA-Seq and target mRNAs of rice sheath blight pathogen provides new insights into pathogenic regulatory mechanismsRunmao Lin, Liye He, Jiayu He, et al.
Nature Protocols|November 23, 2023
Robust scoring of selective drug responses for patient-tailored therapy selectionYingjia Chen, Liye He, Aleksandr Ianevski, et al.
NPJ Systems Biology and Applications|July 18, 2019
Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancerJing Tang, Prson Gautam, Abhishekh Gupta, et al.
Cancer Research|May 12, 2025
A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid LeukemiaYingjia Chen, Liye He, Aleksandr Ianevski, et al.
Briefings in Bioinformatics|August 3, 2021
Network-guided identification of cancer-selective combinatorial therapies in ovarian cancerLiye He, Daria Bulanova, Jaana Oikkonen, et al.
Cell Chemical Biology|December 26, 2017
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target InteractionsJing Tang, Zia-Ur-Rehman Tanoli, Balaguru Ravikumar, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2025
Protein Profiles Predict Treatment Responses to the PI3K Inhibitor Umbralisib in Patients with Chronic Lymphocytic LeukemiaYanping Yin, Haifeng Xu, Liye He, et al.
Journal of Biomaterials Applications|November 4, 2024
Inhibitory effect of RGD peptide hydrogel on inflammation and angiogenesis in vitroBinlin Chen, Licheng Liang, Dadong Jia, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|July 5, 2016
Comprehensive analysis of microRNA-Seq and target mRNAs of rice sheath blight pathogen provides new insights into pathogenic regulatory mechanismsRunmao Lin, Liye He, Jiayu He, et al.
Nature Protocols|November 23, 2023
Robust scoring of selective drug responses for patient-tailored therapy selectionYingjia Chen, Liye He, Aleksandr Ianevski, et al.
NPJ Systems Biology and Applications|July 18, 2019
Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancerJing Tang, Prson Gautam, Abhishekh Gupta, et al.
Cancer Research|May 12, 2025
A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid LeukemiaYingjia Chen, Liye He, Aleksandr Ianevski, et al.
Briefings in Bioinformatics|August 3, 2021
Network-guided identification of cancer-selective combinatorial therapies in ovarian cancerLiye He, Daria Bulanova, Jaana Oikkonen, et al.
Cell Chemical Biology|December 26, 2017
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target InteractionsJing Tang, Zia-Ur-Rehman Tanoli, Balaguru Ravikumar, et al.
Pageof 2